Literature DB >> 11692159

Three novel mutations in the RET proto-oncogene.

V N Kalinin1, F A Amosenko, M A Shabanov, L N Lubchenko, S B Hosch, R F Garkavtseva, J R Izbicki.   

Abstract

Medullary thyroid carcinoma (MTC) occurs as a sporadic tumor or in connection with inherited cancer syndromes of multiple endocrine neoplasia type 2 and familial MTC. Missense RET proto-oncogene mutations and small in-frame deletions are found in most of the cases. In a significant amount of sporadic MTC cases somatic mutation at codon 918 (exon 16), or at codons 609, 611, 618, 620 (exon 10), or codons 630, 634 (exon 11) appear. We report here on three new somatic cell missense mutations of the RET proto-oncogene associated with sporadic MTC. In one tumor mutation at codon 922 TCC(Ser)-->TTC(Phe) in exon 16 was found. In another tumor two mutations at codons 639 GCA(Ala)-->GGA(Gly) and 641 GCT(Ala)-->CGT(Arg) in the exon 11 were observed. Allele-specific PCR followed by sequencing demonstrated the presence of both mutations at the same allele.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11692159     DOI: 10.1007/s001090100250

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  4 in total

1.  Novel germline mutation in the transmembrane region of RET gene close to Cys634Ser mutation associated with MEN 2A syndrome.

Authors:  M Poturnajova; V Altanerova; L Kostalova; J Breza; C Altaner
Journal:  J Mol Med (Berl)       Date:  2004-12-09       Impact factor: 4.599

2.  The newly detected mutations in the RET proto-oncogene in exon 16 as a cause of sporadic medullary thyroid carcinoma.

Authors:  S Jindrichova; R Kodet; L Krskova; P Vlcek; B Bendlova
Journal:  J Mol Med (Berl)       Date:  2003-11-15       Impact factor: 4.599

3.  A case of Warthin-like papillary thyroid carcinoma with diffuse sclerosing stroma and a novel RET mutation: a new entity or a combined tumour?

Authors:  Fausto Maffini; Daniele Lorenzini; Daniela Lepanto; Elvio De Fiori; Caterina Fumagalli; Alessandra Rappa; Marta Tagliabue; Massimo Barberis
Journal:  Ecancermedicalscience       Date:  2019-10-02

4.  HSP90 inhibition blocks ERBB3 and RET phosphorylation in myxoid/round cell liposarcoma and causes massive cell death in vitro and in vivo.

Authors:  Setareh Safavi; Sofia Järnum; Christoffer Vannas; Sameer Udhane; Emma Jonasson; Tajana Tesan Tomic; Pernilla Grundevik; Henrik Fagman; Magnus Hansson; Zeynep Kalender; Alexandra Jauhiainen; Soheila Dolatabadi; Eva Wessel Stratford; Ola Myklebost; Mikael Eriksson; Göran Stenman; Regine Schneider-Stock; Anders Ståhlberg; Pierre Åman
Journal:  Oncotarget       Date:  2016-01-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.